Results 61 to 70 of about 12,698 (210)
Paroxysmal sympathetic hyperactivity secondary to hypoglycemic encephalopathy: A case report
Journal of Diabetes Investigation, Volume 17, Issue 7, Page 1231-1234, July 2026.ABSTRACT A 48‐year‐old male was admitted to our hospital due to a hypoglycemic coma. Although his blood glucose level was increased after glucose administration, his impaired consciousness persisted. Magnetic resonance imaging indicated hypoglycemic encephalopathy.
Yushi Kohzuki +5 more
wiley +1 more source
Effects of Bromocriptine on Dopamine Turnover with or without Levodopa
, 1996 Bromocriptine, a dopamine agonist, alleviates symptoms of Parkinson's disease, even when administered alone, and is used for its treatment. Better therapeutic effects are, however, achieved when bromocriptine is used in combination with levodopa.
M Asanvma +5 more
core +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Peripartum cardiomyopathy (PPCM) is defined as the onset of left ventricular systolic dysfunction either during pregnancy or up to 5 months after delivery, without any other known cause of heart failure. The exact pathogenesis of this disease is unknown, and its prognosis remains poorly understood.
Muhammad Ibrahim Shah +4 more
wiley +1 more source
Notch2 d/d females were more sensitive to bromocriptine-induced pituitary Prl blockage.
, 2021 (A) Females pretreated with bromocriptine exhibited impaired implantation despite the presence of morphologically normal blastocysts. (B) The size of implantation sites in Notch2 d/d mice pretreated with bromocriptine was smaller compared to Notch2 f/f ...
Lili Du (500104) +11 more
core +1 more source
Chemical Biology &Drug Design, Volume 107, Issue 6, June 2026.Total flavonoid intake was significantly inversely associated with neurodegenerative diseases risk. Participants in the highest quartile (Q4) of total flavonoid intake exhibited a 48% lower risk compared to those in the lowest quartile (Q1) (OR = 0.52, 95% CI: 0.31–0.90; p for trend = 0.016).
Chenzhong Zong +5 more
wiley +1 more source
Bromocriptine for Idiopathic Intracranial Hypertension: A Retrospective Multicenter Cohort Study [PDF]
Mahmoud M Morsy,1,* Ahmed Y Azzam,1,* Mohammed Tarek Mirdad,2 Alsaleem Mohammed Abadi,3 Saif Aboud M Alqahtani,4 Hana J Abukhadijah,5 Osman Elamin,6 Mohamed D Morsy,7 David J Altschul8,9 1October 6 University Hospital, October 6 University, Giza,
Abadi AM +8 more
core
Bromocriptine — an old drug in a new formulation for the effective treatment of type 2 diabetes [PDF]
, 2011 Quick-release bromocriptine mesylate was approved by the Food and Drug Administration (FDA) in May 2009, for the treatment of type 2 diabetes (T2DM).
Pertyńska-Marczewska, Magdalena +1 more
core
Phenotypic Clues in Infantile‐Onset Parkinsonism‐Dystonia‐2: A Treatable Neurotransmitter Disorder
Movement Disorders Clinical Practice, Volume 13, Issue 9, Page 2288-2292, September 2026.
Sangeetha Yoganathan +10 more
wiley +1 more source
The FASEB Journal, Volume 40, Issue 9, 15 May 2026.Interplay between VEGF‐A‐driven angiogenesis and DRD2‐mediated inhibition. Tumor‐derived VEGF‐A activates VEGFR2 on endothelial cells, triggering proangiogenic signaling pathways that promote abnormal vessel growth and vascular leakage. VEGF‐A also induces DRD2 expression, establishing a feedback mechanism.
Venu Akkanapally +6 more
wiley +1 more source
Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma
Clinical and Translational Medicine, Volume 16, Issue 5, May 2026.Retroperitoneal sarcoma cells can secrete prolactin into the bloodstream, inducing hyperprolactinaemia, which subsequently triggers metabolic reprogramming, such as glucose metabolism. SOX4 can function as a transcription factor that facilitates PRL transcription.
Fu'an Xie +21 more
wiley +1 more source